Advanced Search
Contact | Corporate | Help

Initial Study of Rituximab to Treat Primary Biliary Cirrhosis

Sponsors:
  • University of California, Davis
  • Genentech
Phases:
  • Phase I
  • Phase II
IndicationsAcronym:
  • Primary Biliary Cirrhosis
Age Groups:
  • Adult
Gender:
Female
Names:
  • Drug: rituximab
Enrollment:
10

Additional information about NCT00364819.


SourceSolution © 2008-2012